Phylodynamic Analysis of Ebola Virus Disease Transmission in Sierra Leone.
Ebola virus
Ebola virus disease
Filoviridae
Sierra Leone
West Africa
filovirus
phylodynamics
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
16 01 2019
16 01 2019
Historique:
received:
27
12
2018
revised:
11
01
2019
accepted:
14
01
2019
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
7
6
2019
Statut:
epublish
Résumé
We generated genome sequences from 218 cases of Ebola virus disease (EVD) in Sierra Leone (SLE) during 2014⁻2015 to complement available datasets, particularly by including cases from a period of low sequence coverage during peak transmission of Ebola virus (EBOV) in the highly-affected Western Area division of SLE. The combined dataset was utilized to produce phylogenetic and phylodynamic inferences, to study sink⁻source dynamics and virus dispersal from highly-populated transmission hotspots. We identified four districts in SLE where EBOV was introduced and transmission occurred without onward exportation to other districts. We also identified six districts that substantially contributed to the dispersal of the virus and prolonged the EVD outbreak: five of these served as major hubs, with lots of movement in and out, and one acted primarily as a source, exporting the virus to other areas of the country. Positive correlations between case numbers, inter-district transition events, and district population sizes reaffirm that population size was a driver of EBOV transmission dynamics in SLE. The data presented here confirm the role of urban hubs in virus dispersal and of a delayed laboratory response in the expansion and perpetuation of the EVD outbreak in SLE.
Identifiants
pubmed: 30654482
pii: v11010071
doi: 10.3390/v11010071
pmc: PMC6356631
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : South African Medical Research Council
ID : Strategic Health Innovation Partnerships Program
Pays : International
Références
Lancet. 2018 Jun 16;391(10138):2395-2398
pubmed: 29916371
Infect Ecol Epidemiol. 2015 Jun 24;5:27060
pubmed: 26112265
N Engl J Med. 2015 Dec 17;373(25):2448-54
pubmed: 26465384
BMC Genomics. 2008 Jan 07;9:5
pubmed: 18179705
Nature. 2008 May 29;453(7195):615-9
pubmed: 18418375
PLoS One. 2012;7(8):e42882
pubmed: 22900061
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
J Infect Dis. 2016 Oct 15;214(suppl 3):S110-S121
pubmed: 27402779
Nature. 2015 Aug 6;524(7563):93-6
pubmed: 25970247
Clin Infect Dis. 2019 Jan 7;68(2):330-333
pubmed: 29961823
Lancet. 2018 Jul 21;392(10143):213-221
pubmed: 30047375
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
Cell. 2015 Jun 18;161(7):1516-26
pubmed: 26091036
Cell Host Microbe. 2015 Dec 9;18(6):659-69
pubmed: 26651942
Mol Biol Evol. 2013 Mar;30(3):713-24
pubmed: 23180580
Nature. 2017 Apr 20;544(7650):309-315
pubmed: 28405027
MMWR Morb Mortal Wkly Rep. 2015 Oct 09;64(39):1108-11
pubmed: 26447483
JCI Insight. 2017 Aug 3;2(15):
pubmed: 28768904
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
PLoS Negl Trop Dis. 2017 Jun 19;11(6):e0005665
pubmed: 28628619
J Clin Microbiol. 2016 Feb;54(2):359-67
pubmed: 26637383
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Nat Biotechnol. 2018 Jul 6;36(7):563-565
pubmed: 29979662